ATS: COPD Drugs Slow Disease Progression, Study Confirms

May 22, 2007

SAN FRANCISCO -- Inhaled corticosteroid and long-acting beta2 agonist therapy significantly slows the progressive lung function decline of chronic obstructive pulmonary disease (COPD).

SAN FRANCISCO, May 22 -- Inhaled corticosteroid and long-acting beta2 agonist therapy significantly slows the progressive lung function decline of chronic obstructive pulmonary disease (COPD).

Fluticasone proprionate plus salmeterol (Advair) reduced the decline in forced expiratory volume (FEV1) by 16 mL per year compared with placebo (P